A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema

Нарушенная траектория развития микробиома и метаболома кишечника у младенцев при атопической экземе
Jan Knol, Stephan Christoph Schuster, Staffan J. Kjelleberg, Keith M. Godfrey, Chiung‐Hui Huang, Daniela I. Drautz‐Moses, Kok Hian Tan, Yiong Huak Chan, Yap Seng Chong, Fabian K. P. Yap, Neerja Karnani, Eric Chun Yong Chan, Bee Wah Lee, Lynette Pei‐Chi Shek, Le Duc Huy Ta, James Chun Yip Chan, Gaik Chin Yap, Rikky W. Purbojati, Koh Yanqing Michelle, Carina Jing Xuan Tay, Dorinda Yan Qin Kioh, Jia Yun Woon, Elizabeth Huiwen Tham, Evelyn Xiu Ling Loo, Anne Goh, Hugo P.S. Van Bever, Oon Hoe Teoh, Christophe Lay
2020-10-06

allergen sensitizationatopic eczemabutyrate and propionate productioninfant gut microbiomeintegrated multi-omics
Evidence is accumulating that the establishment of the gut microbiome in early life influences the development of atopic eczema. In this longitudinal study, we used integrated multi-omics analyses to infer functional mechanisms by which the microbiome modulates atopic eczema risk. We measured the functionality of the gut microbiome and metabolome of 63 infants between ages 3 weeks and 12 months with well-defined eczema cases and controls in a sub-cohort from the Growing Up in Singapore Toward healthy Outcomes (GUSTO) mother-offspring cohort. At 3 weeks, the microbiome and metabolome of allergen-sensitized atopic eczema infants were characterized by an enrichment of Escherichia coli and Klebsiella pneumoniae, associated with increased stool D-glucose concentration and increased gene expression of associated virulence factors. A delayed colonization by beneficial Bacteroides fragilis and subsequent delayed accumulation of butyrate and propionate producers after 3 months was also observed. Here, we describe an aberrant developmental trajectory of the gut microbiome and stool metabolome in allergen sensitized atopic eczema infants.The infographic describes an impaired developmental trajectory of the gut microbiome and metabolome in allergen-sensitized atopic eczema (AE) infants and infer its contribution in modulating allergy risk in the Singaporean mother-offspring GUSTO cohort. The key microbial signature of AE is characterized by (1) an enrichment of Escherichia coli and Klebsiella pneumoniae which are associated with accumulation of pre-glycolysis intermediates (D-glucose) via the trehalose metabolic pathway, increased gene expression of associated virulence factors (invasin, adhesin, flagellin and lipopolysaccharides) by utilizing ATP from oxidative phosphorylation and delayed production of butyrate and propionate, (2) depletion of Bacteroides fragilis which resulted in lower expression of immunostimulatory bacterial cell envelope structure and folate (vitamin B9) biosynthesis pathway, and (3) accompanied depletion of bacterial groups with the ability to derive butyrate and propionate through direct or indirect pathways which collectively resulted in reduced glycolysis, butyrate and propionate biosynthesis.
1
After three months, eczema infants showed delayed accumulation of bacteria producing the short-chain fatty acids butyrate and propionate.
2
Allergen-sensitized infants who developed atopic eczema showed an aberrant longitudinal developmental trajectory of gut microbiome and metabolome from 3 weeks to 12 months.
3
At three weeks, Escherichia coli and Klebsiella pneumoniae were enriched and associated with increased stool D-glucose and expression of virulence factors, including invasin, adhesin, flagellin, and lipopolysaccharides.
4
Bacteroides fragilis colonization was delayed in eczema infants, accompanied by reduced expression of immunostimulatory bacterial cell-envelope structures and folate-related functions.
5
The observed microbial and metabolic disruptions suggest mechanisms by which early-life gut development may modulate atopic eczema and allergy risk.

The developmental trajectory of the gut microbiome and stool metabolome in allergen-sensitized infants with atopic eczema

Aberrant microbial colonization, metabolite accumulation, functional gene expression, and production of butyrate and propionate associated with atopic eczema risk

Publication Details
Publication Date
2020-10-06
Journal
Publisher
ISSN
Cited by
123
Access Type
Author Information
Authors
Jan Knol
Stephan Christoph Schuster
Staffan J. Kjelleberg
Keith M. Godfrey
Chiung‐Hui Huang
Daniela I. Drautz‐Moses
Kok Hian Tan
Yiong Huak Chan
Yap Seng Chong
Fabian K. P. Yap
Neerja Karnani
Eric Chun Yong Chan
Bee Wah Lee
Lynette Pei‐Chi Shek
Le Duc Huy Ta
James Chun Yip Chan
Gaik Chin Yap
Rikky W. Purbojati
Koh Yanqing Michelle
Carina Jing Xuan Tay
Dorinda Yan Qin Kioh
Jia Yun Woon
Elizabeth Huiwen Tham
Evelyn Xiu Ling Loo
Anne Goh
Hugo P.S. Van Bever
Oon Hoe Teoh
Christophe Lay
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%